David Rolfe - Wedgewood Partners
Holding/activity history for Bristol-Myers Squibb (BMY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q1 | 0 | 0 | Sell 100.00% | 0.06 | |
| 2022 Q4 | 4,175 | 0.06 | Reduce 23.04% | 0.02 | $71.86 |
| 2022 Q3 | 5,425 | 0.07 | Reduce 8.44% | 0.01 | $70.97 |
| 2022 Q2 | 5,925 | 0.08 | Reduce 14.44% | 0.01 | $76.96 |
| 2022 Q1 | 6,925 | 0.07 | Add 48.13% | 0.02 | $72.92 |
| 2021 Q4 | 4,675 | 0.04 | Reduce 11.79% | 0.01 | $62.25 |
| 2021 Q3 | 5,300 | 0.04 | Reduce 5.78% | 0.00 | $59.06 |
| 2021 Q2 | 5,625 | 0.05 | Reduce 92.58% | 0.62 | $66.67 |
| 2021 Q1 | 75,835 | 0.74 | Reduce 85.87% | 4.50 | $63.12 |
| 2020 Q4 | 536,807 | 3.83 | Add 22.19% | 0.70 | $48.00 |
| 2020 Q3 | 439,319 | 4.19 | Add 17.53% | 0.63 | $60.29 |
| 2020 Q2 | 373,781 | 3.72 | Add 44.22% | 1.14 | $58.80 |
| 2020 Q1 | 259,180 | 2.74 | Reduce 33.79% | 1.40 | $55.74 |
| 2019 Q4 | 391,442 | 2.55 | Buy | 2.55 | $64.19 |